Actively Recruiting

Phase Not Applicable
Age: 18Months +
FEMALE
NCT04740697

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Led by Institut Claudius Regaud · Updated on 2026-04-20

200

Participants Needed

1

Research Sites

363 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a pilot, prospective, interventional, monocentric study designed to evaluate, in a real-life situation, adherence to tamoxifen treatment as a function of the taking of alternative and complementary therapies in patients with localized hormone-dependent breast cancer. 200 patients will be included in the study. Each patient will be followed for one day.

CONDITIONS

Official Title

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Who Can Participate

Age: 18Months +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at study entry
  • Diagnosed with hormone-dependent localized breast cancer requiring adjuvant hormonal therapy with tamoxifen
  • Treated with tamoxifen for a maximum duration of 1 to 3 years
  • Affiliated with a Social Security system in France
  • Provided informed consent before participating in the study
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women
  • Any psychological, family, geographical, or sociological condition preventing medical follow-up or study procedure compliance
  • Patients under legal protection or who have forfeited their freedom by administrative or legal decision

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

F

Florence DALENC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here